Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Francisco J Caballero-CaminoFernando P Cossío

Abstract

Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current surgical and pharmacological approaches are ineffective, and liver transplantation represents the only curative option. Ursodeoxycholic acid (UDCA) and histone deacetylase 6 inhibitors (HDAC6is) have arisen as promising therapeutic strategies, but with partial benefits. Here, we tested an approach based on the design, synthesis, and validation of a family of UDCA synthetic conjugates with selective HDAC6i capacity (UDCA-HDAC6i). Four UDCA-HDAC6i conjugates presented selective HDAC6i activity, UDCA-HDAC6i #1 being the most promising candidate. UDCA orientation within the UDCA-HDAC6i structure was determinant for HDAC6i activity and selectivity. Treatment of polycystic rats with UDCA-HDAC6i #1 reduced their hepatomegaly and cystogenesis, increased UDCA concentration, and inhibited HDAC6 activity in liver. In cystic cholangiocytes UDCA-HDAC6i #1 restored primary cilium length and exhibited potent antiproliferative activity. UDCA-HDAC6i #1 was actively transported into cells through BA and organic cation transporters. These UDCA-HDAC6i conjugates open a therapeutic avenue for PLDs.

References

Jan 1, 1994·Scandinavian Journal of Gastroenterology. Supplement·A F Hofmann
Apr 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Stephen J HaggartyStuart L Schreiber
Nov 14, 2003·Journal of Medicinal Chemistry·Thomas A MillerSandro Belvedere
Oct 29, 2004·The American Journal of Pathology·Tatyana V MasyukNicholas F Larusso
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manisha H ShahMichael Grever
Jul 3, 2007·Cell·Junmin Pan, William Snell
May 20, 2008·Cellular and Molecular Life Sciences : CMLS·A F Hofmann, L R Hagey
Dec 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jesús M BanalesNicholas F LaRusso
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew A Lane, Bruce A Chabner
Jun 12, 2010·Current Topics in Medicinal Chemistry·Sandra C MwakwariAdegboyega K Oyelere
Jul 10, 2010·Journal of the American Chemical Society·Kyle V ButlerAlan P Kozikowski
Jul 29, 2010·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Stephen B MasonVincent H Gattone
Sep 28, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Carine SteinerKatharina M Rentsch
Nov 17, 2010·Cancer Letters·Alexander ArltHeiner Schäfer
Jun 26, 2012·Biochemical Pharmacology·Sabrina DallavalleFranco Zunino
Jan 9, 2013·Nature Reviews. Gastroenterology & Hepatology·Tom J G Gevers, Joost P H Drenth
Jan 17, 2013·British Journal of Cancer·M KaliszczakE O Aboagye
Feb 2, 2013·Cancer Research·Sergio A GradiloneNicholas F LaRusso
Jan 18, 2014·The American Journal of Pathology·Sergio A GradiloneNicholas F Larusso
Oct 1, 2014·Nature Reviews. Gastroenterology & Hepatology·Maria J PerugorriaJesus M Banales
Apr 29, 2015·Current Drug Targets·Tatyana V MasyukNicholas F LaRusso
Apr 29, 2015·Journal of Hepatology·Ulrich BeuersRaoul Poupon
Jun 6, 2015·Journal of Hepatology·Patricia Munoz-GarridoJesús M Banales
Aug 19, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elisa LozanoRocio I R Macias
May 24, 2016·Journal of Hepatology·Hedwig M A D'AgnoloJoost P H Drenth
Jun 21, 2016·Cell Metabolism·Annika WahlströmFredrik Bäckhed
Jul 28, 2016·Nature Chemical Biology·Yasuyuki MiyakePatrick Matthias
Jul 28, 2016·Nature Chemical Biology·Yang Hai, David W Christianson
Feb 12, 2017·Current Medicinal Chemistry·Kai ChengChenzhong Liao
Jun 20, 2017·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Adrian P MansiniSergio A Gradilone
Jul 28, 2017·American Journal of Physiology. Renal Physiology·Murali K YandaLiudmila Cebotaru
Nov 7, 2017·Liver Research·John Y L Chiang
Nov 8, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wen-Bin ZhangZuo-Jiong Gong

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
surgical resection
acetylation
X‐ray
flow cytometry

Software Mentioned

Maestro
Pymol
GraphPad Prism
GraphPad
LigPrep
QikProp
XP GlideScore
Glide
Prime
Maestro package

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.